EX-99.1 2 novt-ex99_1.htm EX-99.1 EX-99.1

Exhibit 99.1

Revenue, Gross Profit, Gross Profit Margin and Operating Income (Loss) by Reportable Segment

(in thousands of U.S. dollars, except percentages)

(Unaudited)

 

 

Three Months Ended

 

March 31, 2023

June 30, 2023

September 29, 2023

December 31, 2023

 

March 29, 2024

June 28, 2024

September 27, 2024

December 31, 2024

Revenue:

 

 

 

 

 

 

 

 

 

Automation Enabling Technologies

$128,003

$131,995

$121,943

$117,279

 

$117,389

$116,729

$128,704

$127,798

Medical Solutions

91,123

97,469

99,560

94,290

 

113,527

119,135

115,701

110,262

Total

$219,126

$229,464

$221,503

$211,569

 

$230,916

$235,864

$244,405

$238,060

 

 

 

 

 

 

 

 

 

 

Gross Profit (GAAP):

 

 

 

 

 

 

 

 

 

Automation Enabling Technologies

$58,407

$63,270

$58,888

$54,233

 

$55,502

$54,995

$60,562

$63,916

Medical Solutions

40,627

42,409

43,999

43,752

 

46,222

49,337

49,428

44,970

Unallocated

(1,406)

(1,556)

(1,296)

(1,430)

 

(1,308)

(643)

(775)

(661)

Total

$97,628

$104,123

$101,591

$96,555

 

$100,416

$103,689

$109,215

$108,225

 

 

 

 

 

 

 

 

 

 

Gross Profit Margin (GAAP):

 

 

 

 

 

 

 

 

 

Automation Enabling Technologies

45.6%

47.9%

48.3%

46.2%

 

47.3%

47.1%

47.1%

50.0%

Medical Solutions

44.6%

43.5%

44.2%

46.4%

 

40.7%

41.4%

42.7%

40.8%

Total

44.6%

45.4%

45.9%

45.6%

 

43.5%

44.0%

44.7%

45.5%

 

 

 

 

 

 

 

 

 

 

Operating Expense (GAAP):

 

 

 

 

 

 

 

 

 

Research and development and engineering

$11,097

$10,904

$10,230

$10,793

 

$9,997

$9,977

$8,860

$10,192

Selling, general and administrative

18,336

18,216

17,536

18,772

 

18,494

18,893

18,016

20,020

Amortization of purchased intangible assets

3,227

3,241

3,243

3,231

 

2,801

2,796

2,813

2,797

Restructuring, acquisition and related costs

2,184

930

3,629

2,948

 

279

1,810

809

18

Automation Enabling Technologies

$34,844

$33,291

$34,638

$35,744

 

$31,571

$33,476

$30,498

$33,027

 

 

 

 

 

 

 

 

 

 

Research and development and engineering

$11,954

$12,659

$11,991

$12,836

 

$13,266

$13,901

$14,519

$15,424

Selling, general and administrative

11,761

12,809

12,325

12,332

 

13,622

12,815

13,774

13,587

Amortization of purchased intangible assets

1,862

1,883

1,887

1,871

 

2,949

4,112

3,776

3,750

Restructuring, acquisition and related costs

87

95

280

897

 

366

361

1,037

5,166

Medical Solutions

$25,664

$27,446

$26,483

$27,936

 

$30,203

$31,189

$33,106

$37,927

 

 

 

 

 

 

 

 

 

 

Operating Income (Loss) (GAAP):

 

 

 

 

 

 

 

 

 

Automation Enabling Technologies

$23,564

$29,979

$24,249

$18,489

 

$23,930

$21,519

$30,063

$30,891

Medical Solutions

14,961

14,963

17,517

15,817

 

16,020

18,149

16,323

7,040

Unallocated

(12,213)

(12,744)

(11,457)

(12,629)

 

(14,342)

(13,953)

(13,831)

(11,225)

Total

$26,312

$32,198

$30,309

$21,677

 

$25,607

$25,715

$32,555

$26,707